×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NBY – novabay pharmaceuticals, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NBY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/17
03:02 am
nby
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
11/15
08:04 am
nby
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand [Yahoo! Finance]
Low
Report
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand [Yahoo! Finance]
11/15
08:00 am
nby
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
Low
Report
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals’ Proposals to Authorize the Sale of its Avenova Brand
11/11
01:23 pm
nby
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) had its price target lowered by analysts at Ascendiant Capital Markets from $8.00 to $0.85. They now have a "buy" rating on the stock.
Low
Report
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) had its price target lowered by analysts at Ascendiant Capital Markets from $8.00 to $0.85. They now have a "buy" rating on the stock.
11/9
02:07 am
nby
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
11/7
04:05 pm
nby
NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
Low
Report
NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
11/6
05:06 pm
nby
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price [Yahoo! Finance]
Medium
Report
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price [Yahoo! Finance]
11/6
04:05 pm
nby
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
High
Report
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/15
08:11 am
nby
Form DEFA14A NovaBay Pharmaceuticals,
Low
Report
Form DEFA14A NovaBay Pharmaceuticals,
11/13
05:15 pm
nby
Form DEFA14A NovaBay Pharmaceuticals,
Low
Report
Form DEFA14A NovaBay Pharmaceuticals,
11/12
04:53 pm
nby
Form DEFA14A NovaBay Pharmaceuticals,
High
Report
Form DEFA14A NovaBay Pharmaceuticals,
11/12
09:20 am
nby
Form DEFA14A NovaBay Pharmaceuticals,
High
Report
Form DEFA14A NovaBay Pharmaceuticals,
11/8
05:34 pm
nby
Form SC 13G/A NovaBay Pharmaceuticals, Filed by: Hudson Bay Capital Management LP
Medium
Report
Form SC 13G/A NovaBay Pharmaceuticals, Filed by: Hudson Bay Capital Management LP
11/7
04:15 pm
nby
Form 10-Q NovaBay Pharmaceuticals, For: Sep 30
Low
Report
Form 10-Q NovaBay Pharmaceuticals, For: Sep 30
11/6
04:59 pm
nby
Form DEFA14A NovaBay Pharmaceuticals,
Medium
Report
Form DEFA14A NovaBay Pharmaceuticals,
11/6
04:46 pm
nby
Form 8-K NovaBay Pharmaceuticals, For: Nov 05
Low
Report
Form 8-K NovaBay Pharmaceuticals, For: Nov 05
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/19
NovaBay Pharmaceuticals to Hold 2019 Fourth Quarter and Full Year Conference Call on March 26, 2020
361.4%
4/20 NovaBay Pharmaceuticals Signs Agreement to Distribute COVID-19 Antibody Rapid Point-of-Care Test to U.S. Healthcare Professionals 134.9%
5/13 Form 8-K NovaBay Pharmaceuticals, For: May 09 128.1%
7/29 NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million 37.0%
3/20 Form 8-K NovaBay Pharmaceuticals, For: Mar 18 24.3%
11/4 NovaBay Pharmaceuticals Launches Online Sales of CelleRx® Skin Cleanser for Post-Aesthetic Dermatology and Cosmetic Surgery Procedures 20.8%
11/18 NovaBay Pharmaceuticals Launches NovaSight™ Daily Vitamin for Ocular Health on Amazon.com 18.4%
3/16 Form 8-K NovaBay Pharmaceuticals, For: Mar 11 13.9%
3/25 NovaBay Pharmaceuticals Announces the Availability of KN95 Disposable Masks on Avenova.com 13.7%
9/13 Form EFFECT NovaBay Pharmaceuticals, 13.7%
4/20 NovaBay Pharmaceuticals Signs Agreement to Distribute COVID-19 Antibody Rapid Point-of-Care Test to U.S. Healthcare Professionals 134.9%
5/13 Form 8-K NovaBay Pharmaceuticals, For: May 09 128.1%
7/29 NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million 37.0%
3/20 Form 8-K NovaBay Pharmaceuticals, For: Mar 18 24.3%
11/4 NovaBay Pharmaceuticals Launches Online Sales of CelleRx® Skin Cleanser for Post-Aesthetic Dermatology and Cosmetic Surgery Procedures 20.8%
11/18 NovaBay Pharmaceuticals Launches NovaSight™ Daily Vitamin for Ocular Health on Amazon.com 18.4%
3/16 Form 8-K NovaBay Pharmaceuticals, For: Mar 11 13.9%
3/25 NovaBay Pharmaceuticals Announces the Availability of KN95 Disposable Masks on Avenova.com 13.7%
9/13 Form EFFECT NovaBay Pharmaceuticals, 13.7%
TOP News Decliners
3/19
Form 3 NovaBay Pharmaceuticals, For: Dec 31 Filed by: Xu Wang
-45.8%
5/9 Q1/2019 3/31/2019 EPS -0.280 ZacksConsensus N/A ActVsEst N/A - N/A -33.3%
11/7 Q3/2019 9/30/2019 EPS -0.020 ZacksConsensus N/A ActVsEst N/A - N/A -21.8%
6/13 Form 4 NovaBay Pharmaceuticals, For: Jun 11 Filed by: Pioneer Pharma (Hong Kong) Co Ltd -18.1%
5/21 Form 8-K NovaBay Pharmaceuticals, For: May 16 -17.9%
8/9 Form 8-K NovaBay Pharmaceuticals, For: Aug 08 -17.3%
5/15 Thinking about buying stock in Aurora Cannabis, Alibaba, Macy's, Novabay Pharmaceuticals, or Tilray? -13.1%
3/26 Q4/2019 12/31/2019 EPS -0.130 ZacksConsensus N/A ActVsEst N/A - N/A -11.6%
7/1 Form 8-K NovaBay Pharmaceuticals, For: Jul 01 -8.9%
7/25 Form 8-K NovaBay Pharmaceuticals, For: Jul 20 -8.9%
5/9 Q1/2019 3/31/2019 EPS -0.280 ZacksConsensus N/A ActVsEst N/A - N/A -33.3%
11/7 Q3/2019 9/30/2019 EPS -0.020 ZacksConsensus N/A ActVsEst N/A - N/A -21.8%
6/13 Form 4 NovaBay Pharmaceuticals, For: Jun 11 Filed by: Pioneer Pharma (Hong Kong) Co Ltd -18.1%
5/21 Form 8-K NovaBay Pharmaceuticals, For: May 16 -17.9%
8/9 Form 8-K NovaBay Pharmaceuticals, For: Aug 08 -17.3%
5/15 Thinking about buying stock in Aurora Cannabis, Alibaba, Macy's, Novabay Pharmaceuticals, or Tilray? -13.1%
3/26 Q4/2019 12/31/2019 EPS -0.130 ZacksConsensus N/A ActVsEst N/A - N/A -11.6%
7/1 Form 8-K NovaBay Pharmaceuticals, For: Jul 01 -8.9%
7/25 Form 8-K NovaBay Pharmaceuticals, For: Jul 20 -8.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: